Tanja Maria Rosenkilde Kjær,Birgitte Andersen,Karoline Sidelmann Brinch
申请号：
US14942307
公开号：
US09833495B2
申请日:
2015.11.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Treatment of an inflammatory bowel disease in a subject in need thereof by simultaneous or successive parenteral and oral administration of a mammalian beta defensin is described. Oral administration of mammalian beta defensin to a subject during remission to keep said subject suffering from IBD in remission, prolong remission in said subject suffering from IBD, to reduce the occurrence of relapse in said subject suffering from IBD, or any combination thereof, is also described.
